Fairmount Funds Management LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-23 6:32 pm Purchase | 2025-06-13 | 13D | Crescent Biopharma, Inc. CBIO | Fairmount Funds Management LLC | 3,124,220 19.990% | 3,124,220 (New Position) | Filing |